A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China
Authors:
- Department of ImmunologyDIDepartment of Immunology
- Dalin LiDLDalin Li
- Dianjun LiDLDianjun Li
- College of Bioinformatics Science and TechnologyCTCollege of Bioinformatics Science and Technology
Open Access
- 1 January 2016
- journal article
- Published by Chinese Journal of Cancer Research in Chinese Journal of Cancer Research
- Vol. 28 (4) , 435-443
Abstract
The inhibition of the neovascularization in tumors is a potential therapeutic target of cancer. Vascular endothelial growth inhibitor (VEGI) is a member of the TNF superfamily which has the ability to suppress the formation of new vessels in tumors. In order to study the association between VEGI gene polymorphisms and breast cancer risk, a case-control study was conducted in Chinese Han women in Northeast China. Our study involved 708 female breast cancer patients and 685 healthy volunteers. Four SNPs of VEGI gene were analyzed through the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The association between VEGI gene polymorphisms and breast cancer risk was analyzed in our study. The relation between VEGI gene variants and clinical features of breast cancer including lymph node (LN) metastasis, estrogen receptor (ER), progestrogen receptor (PR), tumor protein 53 (p53), human epidermal growth factor receptor 2 (Her-2) and triple negative (ER-/PR-/Her-2-) status was analyzed as well. We found that the CT genotype and T allele of rs6478106 were more frequent in patients than in controls. There was also a statistical difference in the distribution of Crs6478106Grs4263839 haplotype between patients and controls. In addition, SNP rs6478106 and rs4979462 were related with the Her-2 status. Our results suggest that VEGI gene variants may be related to the breast cancer risk and the clinical features of breast cancer in Chinese Han women in Northeast China.Keywords
This publication has 33 references indexed in Scilit:
- Presentation delay in breast cancer patients and its association with sociodemographic factors in North Pakistan2015
- Epidemiology of Breast CancerSurgical Oncology Clinics of North America, 2014
- Genetic and epigenetic aspects of breast cancer progression and therapy.2014
- Polymorphisms of ERBB2 and breast cancer risk: A meta-analysis of 26 studies involving 35,088 subjectsJournal of Surgical Oncology, 2013
- Breast cancer intratumor genetic heterogeneity: causes and implicationsExpert Review of Anticancer Therapy, 2012
- Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of Northeast ChinaMolecular and Cellular Biochemistry, 2012
- The T Cell Costimulator TL1A Is Induced by FcγR Signaling in Human Monocytes and Dendritic CellsThe Journal of Immunology, 2007
- VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor GrowthClinical Cancer Research, 2005
- TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell CostimulatorImmunity, 2002
- Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth InhibitorCirculation Research, 2001